Evidence map›Paper›PMID 34356333›Full record

ArticleAntioxidants (Basel, Switzerland)2021

TCA Cycle and Fatty Acids Oxidation Reflect Early Cardiorenal Damage in Normoalbuminuric Subjects with Controlled Hypertension.

Aranzazu Santiago-Hernandez, Marta Martin-Lorenzo, Ariadna Martin-Blazquez, Gema Ruiz-Hurtado, Maria G Barderas, Julian Segura, Luis M Ruilope, Gloria Alvarez-Llamas

Abstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Aranzazu Santiago-HernandezImmunology Department, IIS-Fundación Jiménez Díaz-UAM, 28040 Madrid, Spain.
Marta Martin-LorenzoImmunology Department, IIS-Fundación Jiménez Díaz-UAM, 28040 Madrid, Spain.ORCID 0000-0002-0950-3558
Ariadna Martin-BlazquezImmunology Department, IIS-Fundación Jiménez Díaz-UAM, 28040 Madrid, Spain.ORCID 0000-0002-4205-3499
Gema Ruiz-HurtadoCardiorenal Translational Laboratory, Institute of Research i+12, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
Maria G BarderasDepartment of Vascular Physiopathology, Hospital Nacional de Parapléjicos, SESCAM, 45071 Toledo, Spain.ORCID 0000-0003-4290-4721
Julian SeguraHypertension Unit, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
Luis M RuilopeCardiorenal Translational Laboratory, Institute of Research i+12, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
Gloria Alvarez-LlamasImmunology Department, IIS-Fundación Jiménez Díaz-UAM, 28040 Madrid, Spain.ORCID 0000-0002-3313-721X

Funding

Comunidad de Madrid PEJD-2019-PRE/BMD-16992, 2018-T2/BMD-11561Fundación Conchita Rábago NAFundacion SENEFRO / SEN NAGetinge Group Spain SL NAInstituto de Salud Carlos III PI16/01334, PI20/01103, PI17/01093, PI17/01193, IF08/3667-1, CPII15/00027, CP15/00129, CPII20/00022, PT13/0001/0013, PRB3 [IPT17/0019-ISCIII-SGEFI/ERDF]); REDinREN (RD16/0009)
6 · The paper itself

Abstract

Moderately increased albuminuria, defined by an albumin to creatinine ratio (ACR) > 30 mg/g, is an indicator of subclinical organ damage associated with a higher risk of cardiovascular and renal disease. Normoalbuminuric subjects are considered at no cardiorenal risk in clinical practice, and molecular changes underlying early development are unclear. To decipher subjacent mechanisms, we stratified the normoalbuminuria condition. A total of 37 hypertensive patients under chronic renin-angiotensin system (RAS) suppression with ACR values in the normoalbuminuria range were included and classified as control (C) (ACR < 10 mg/g) and high-normal (HN) (ACR = 10-30 mg/g). Target metabolomic analysis was carried out by liquid chromatography and mass spectrometry to investigate the role of the cardiorenal risk urinary metabolites previously identified. Besides this, urinary free fatty acids (FFAs), fatty acid binding protein 1 (FABP1) and nephrin were analyzed by colorimetric and ELISA assays. A Mann-Whitney test was applied, ROC curves were calculated and Spearman correlation analysis was carried out. Nine metabolites showed significantly altered abundance in HN versus C, and urinary FFAs and FABP1 increased in HN group, pointing to dysregulation in the tricarboxylic acid cycle (TCA) cycle and fatty acids β-oxidation. We showed here how cardiorenal metabolites associate with albuminuria, already in the normoalbuminuric range, evidencing early renal damage at a tubular level and suggesting increased β-oxidation to potentially counteract fatty acids overload in the HN range.

Indexed as

albuminuriacardiovascular riskchronic kidney diseasefree fatty acidshigh-normalHypertensionmetabolomicsnormoalbuminuriatricarboxylic acid cycleβ-oxidation

Identifiers

PMID34356333
PMCPMC8301016

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.